Curis (CRIS) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CRIS Hot Sheet
Price: $14.52 -1.69%
Financial Fact:
Net (loss)/income: -28.35M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Net (loss)/income: -28.35M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Curis (NASDAQ: CRIS) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.69 million.
For earnings history and earnings-related data on Curis (CRIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- Customers Bancorp (CUBI) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
